G1 Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Research Triangle Park, NC
SEC filing record 1 source field available
Fiscal year end
31 December
G1 Therapeutics, Inc. has filed 562 SEC EDGAR filings since 12 Oct 2012

SEC filing history

Showing 176-200 of 562 matching filings.

Per page
25
Current page
8
4

PRIMARY DOCUMENT

Filing date
24 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jun 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-265832

S-8

Filing date
24 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38096

GTHX-Q1-2022 10-Q

Filing date
04 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
EFFECT File 333-257640

EFFECT filing

Filing date
03 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38096

DEFA14A

Filing date
28 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38096

DEF 14A

Filing date
28 Apr 2022
Reporting date
23 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-257640

POS AM

Filing date
23 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-257640

POSASR

Filing date
23 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90214

SC 13G/A filing

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90214

SCHEDULE 13G/A

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Feb 2022
Reporting date
07 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90214

SC 13G/A filing

Filing date
03 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90214

FILING G1 THERAPEUTICS, INC.

Filing date
21 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .